Oncoinvent ASA - Disclosure of large shareholding
2026-10-02 09:25:13
Oslo, 2 October 2026: Reference is made to the stock exchange announcement
published by Oncoinvent ASA (the "Company") on 22 September 2026 regarding
completion of a private placement and retail offering of in total 1,650,000 new
shares at a subscription price of NOK 90 per share (the "Private Placement"),
and the mandatory notification of trade and shareholding disclosure published on
23 September 2026 regarding the allocation of new shares to, and temporary share
lending by, Linc AB.
In connection with the Private Placement, Linc AB temporarily lent 555,362
existing and unencumbered shares in the Company to ABG Sundal Collier ASA and
DNB Carnegie, a part of DNB Bank ASA, acting as managers in the Private
Placement (the "Managers"), solely to facilitate delivery-versus-payment ("DVP")
settlement of shares allocated to investors in the Private Placement. Following
registration of the share capital increase pertaining to the Private Placement
with the Norwegian Register of Business Enterprises, the Managers have now re
-delivered the temporarily lent shares to Linc AB, together with the 192,888 new
shares allocated to Linc AB in the Private Placement.
Following re-delivery of all temporarily lent shares and the shares allocated in
the Private Placement, Linc AB holds 748,250 shares and votes in the Company,
equal to 12.21% of the total number of shares and votes in the Company, thereby
crossing above the 5% and 10% reporting thresholds pursuant to the NSTA on a
consolidated basis, as also described in the announcement made on 23 September
2026.
This information is subject to the disclosure requirements pursuant to section 4
-2 of the Norwegian Securities Trading Act.
For further information, please contact:
Oystein Soug, Chief Executive Officer
Email: IR@oncoinvent.com
g\, Chief Executive Officer\
Email: IR@oncoinvent.com\